Dogwood Therapeutics【DWTX】銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

2.9712

買値

2.97

売値

3.02

出来高

24,281,231

2.05 日の範囲 3.99

1.62 52 週間の範囲 5.29

前日終値

1.87

始値

2.635

時刻

2.97

最終取引時間

平均取引量 (3 か月)

47,567

財務取引量

US$ 65,769,123

VWAP

2.7086

Dogwood Therapeutics Announces Patient Dosing in Phase 2b Trial Evaluating Halneuron® in Patients with Chemotherapy Induced Neuropathy (CINP) to Commence First Quarter of 2025

ATLANTA, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), a development-stage biopharmaceutical company focused on advancing first-in class...

Dogwood Therapeutics, Inc. Announces Low Dose IMC-2 Treatment Reduces Long-COVID Related Fatigue and Sleep Disturbance in an Investigator-Initiated Study

- IMC-2 treatment, dosed as valacyclovir 750 mg + celecoxib 200 mg twice daily, demonstrated clinically meaningful reduction in Long-COVID related fatigue and sleep disturbance as compared to...

Dogwood Therapeutics Announces Third Quarter 2024 Financial Results

- Dogwood Therapeutics, Inc. (Nasdaq: “DWTX”) formed in October by combination of Virios Therapeutics, Inc. and Pharmagesic (Holdings) Inc., 100% parent company of Wex Pharmaceuticals, Inc. (the...

Dogwood Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Thursday, November 7, 2024

ATLANTA, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), formerly Virios Therapeutics, Inc., a clinical‐stage biopharmaceutical company, announced...

Dogwood Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement

ATLANTA, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), formerly Virios Therapeutics, Inc., a clinical‐stage biopharmaceutical company, announced...

Virios Therapeutics, Inc. and Wex Pharmaceuticals, Inc. Announce Business Combination to Form Dogwood Therapeutics, Inc. (Nasdaq: “DWTX”)

Strategic financing by an affiliate of CK Life Sciences Int’l., (Holdings) Inc., results in working capital of approximately $23 million to fund operations and advance Phase 2b Halneuron®...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.6612	28.6233766234	2.31	3.24	1.87	30020	2.05470261	CS
4	0.3712	14.2769230769	2.6	3.24	1.87	25092	2.46412396	CS
12	-1.7888	-37.5798319328	4.76	4.9	1.62	47567	2.81290848	CS
26	-0.5788	-16.3042253521	3.55	5.29	1.62	76853	3.43615056	CS
52	-0.5788	-16.3042253521	3.55	5.29	1.62	76853	3.43615056	CS
156	-0.5788	-16.3042253521	3.55	5.29	1.62	76853	3.43615056	CS
260	-0.5788	-16.3042253521	3.55	5.29	1.62	76853	3.43615056	CS

DWTX - Frequently Asked Questions (FAQ)

What is the current Dogwood Therapeutics share price?

The current share price of Dogwood Therapeutics is US$ 2.9712

What is the 1 year trading range for Dogwood Therapeutics share price?

Dogwood Therapeutics has traded in the range of US$ 1.62 to US$ 5.29 during the past year

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
ASSTAsset Entities Inc	US$ 0.8998 (93.71%)	263.47M
DWTXDogwood Therapeutics Inc	US$ 3.18 (70.05%)	24.31M
USEGUS Energy Corp	US$ 3.74 (61.21%)	107.79M
DOGZDogness International Corporation	US$ 27.62 (52.60%)	1.95M
MYNAMynaric AG	US$ 0.6697 (50.83%)	3.72M
GOEVCanoo Inc	US$ 0.3748 (-72.24%)	41.38M
SHOTWSafety Shot Inc	US$ 0.1094 (-47.40%)	18.06k
ORKTOrangeKloud Technology Inc	US$ 0.7068 (-36.89%)	7.48M
HEPAHepion Pharmaceuticals Inc	US$ 0.3219 (-31.36%)	1.66M
WNWMeiwu Technology Company Ltd	US$ 0.2681 (-27.05%)	11.02M
GCTKGlucoTrack Inc	US$ 0.1226 (44.41%)	613.28M
CRKNCrown Electrokinetics Corporation	US$ 0.1121 (-10.32%)	392.52M
ASSTAsset Entities Inc	US$ 0.8998 (93.71%)	262.98M
RIMEAlgorhythm Holdings Inc	US$ 0.034599 (-16.83%)	230.08M
RGTIRigetti Computing Inc	US$ 13.97 (42.12%)	226.81M